The
Campaign

The Concept

behind

Beelieve

campaign

Beelieve is inspired by the bee’s lifecycle. Like a bee that must carry her sting for the rest of her life and visit repeatedly the same place, to perform the same action, accordingly each patient has an autonomous routine and perform injections in specific periods of time. Here comes Beelieve to connect and motivate people that receive the same treatment, as well as to inform audience on understanding the disease and act responsively.

The Heros

that go through

all this

journey

The heroes are unique people we meet every day, and their superpower is not visible at first glance. Their superpower is the persistence on performing an injection treatment for specific periods of time and still Beelieve in the power of the communication and in the power of a community.

The action is to gather patients that receive the injection treatment and collect their syringes in order to create an artwork using the syringes.

The Story

This story will become a roadshow and will be exhibit-ed around city squares, as well as in a digital form which will be accessible by people that learn about Beelieve.

μια πρωτοβουλία της IPSEN

© 2022 Beelieve Campaign. All rights Reserved

Terms & Conditions / Privacy Policy / Cookies Policy

Developed by Reyelise Ltd. / Curation by Get2Work

Αυτές οι πληροφορίες προορίζονται για γενική πληροφόρηση και ενημέρωση του κοινού και σε καμία περίπτωση δεν μπορούν να υποκαταστήσουν την συμβουλή ιατρού ή άλλου αρμόδιου επαγγελματία υγείας.

References
1. Canadian Cancer Society. The neuroendocrine system. https://www.cancer.ca Accessed May 22, 2019.
2. Sackstein PE, O’Neil DS, Neugut AI, et al. Epidemiologic trends in neuroendocrine tumors: an examination of incidence rates and survival of specific patient subgroups over the past 20 years. Seminars in Oncol. 2018;4(13):249–58.
3. Ramirez RA, Chauhan A, Gimenez J, et al. Management of pulmonary neuroendocrine tumors. Rev Endocr Metab Disord. 2017;18(4):433-442.
4. National Cancer Institute. Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®)-Patient Version. 2018. https://www.cancer.gov. Accessed October 22, 2018.
5. National Cancer Institute. Pheochromocytoma and paraganglioma treatment (PDQ®)-patient version. 2017. https://www.cancer.gov. Accessed October 23, 2018.
6. Schernthaner-Reiter MH, Trivellin G, Stratakis CA. MEN1, MEN4, and Carney complex: pathology and molecular genetics. Neuroendocrinology. 2016;103: 18e31.
7. Cancer.NET Editorial Board. Neuroendocrine Tumor of the Pancreas: Symptoms and Signs. 2017. https://www.cancer.net. Accessed October 22, 2018.
8. Singh S, Granberg D, Wolin E, et al. Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs. J Glob Oncol. 2016;2(1):43–53.
9. National Institute of Diabetes and Digestive and Kidney Diseases. Your digestive system and how it works. https://www.niddk.nih.gov. Accessed October 19, 2018.
10. Modlin IM, Latich I, Kidd M, et al. Therapeutic options for gastrointestinal carcinoids. Clin Gastroenterol Hepatol. 2006; 4(5): 526-47, 2006.